The company
Privia Health Group, Inc.
PRVA · Nasdaq
PRVA stood above a rising 150-day average in 19 of the last 52 weekly readings, and has been out of that trend for the last 11 weeks. It is 0.9% below that average now. Providers & Facilities: 51% of its 53 stocks in an uptrend (+8 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Setting up
- Weeks in an uptrend
- out for 11
- Industry in uptrend
- 51% +8 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $43.5M
- Officials’ trades on record
- 6
- Institutions holding
- 276 (+7)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 19 of 52 weeks.
Providers & Facilities: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
6 disclosed lines: House 0, Senate 0, executive 6; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 29 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 15 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 30 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $50k–$100k | 30 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 4 Mar 2026filed 14 May 2026 |
| Arjun Mody Executive branch: Office of Government EthicsSocial Security Administration | sold | $1k–$15k | 30 Jan 2026filed 10 Apr 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| David MountcastleEVP & Chief Financial Officer | sold | 21,275at $27.67 | 9 Jul 2026filed 13 Jul 2026 |
| David MountcastleEVP & Chief Financial Officer | sold | 600at $27.57 | 7 Jul 2026filed 9 Jul 2026 |
| Matthew Shawn MorrisDirector | sold | 53,722at $27.24 | 6 Jul 2026filed 7 Jul 2026 |
| Matthew Shawn MorrisDirector | sold | 59,037at $27.33 | 2 Jul 2026filed 7 Jul 2026 |
| David MountcastleEVP & Chief Financial Officer | sold | 24,734at $27.50 | 2 Jul 2026filed 7 Jul 2026 |
| Matthew Shawn MorrisDirector | sold | 45,634at $26.52 | 1 Jul 2026filed 2 Jul 2026 |
| Matthew Shawn MorrisDirector | sold | 37,041at $26.93 | 1 Jul 2026filed 2 Jul 2026 |
| Matthew Shawn MorrisDirector | sold | 52,823at $25.72 | 30 Jun 2026filed 2 Jul 2026 |
| Matthew Shawn MorrisDirector | sold | 63,212at $25.33 | 29 Jun 2026filed 30 Jun 2026 |
| David MountcastleEVP & Chief Financial Officer | sold | 17,196at $25.18 | 26 Jun 2026filed 30 Jun 2026 |
| Matthew Shawn MorrisDirector | sold | 88,110at $25.33 | 26 Jun 2026filed 30 Jun 2026 |
| Parth MehrotraChief Executive Officer | sold | 15,647at $22.64 | 12 May 2026filed 13 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 21,402,417$550.7M | +2,344,507+12.3% |
| FMR LLCreduced · filed 13 Aug 2026 | 12,848,437$330.6M | -197,105−1.5% |
| Durable Capital Partners LPreduced · filed 14 Aug 2026 | 11,635,948$299.4M | -451,895−3.7% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 6,572,384$169.1M | +290,842+4.6% |
| Rubicon Founders LLCadded · filed 14 Aug 2026 | 5,971,079$153.6M | +22,415+0.4% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 5,156,720$132.7M | +147,897+3.0% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 4,905,789$126.2M | +415,889+9.3% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 3,130,473$80.6M | +234,939+8.1% |
| RIVERBRIDGE PARTNERS LLCreduced · filed 13 Jul 2026 | 2,998,597$77.2M | -919,351−23.5% |
| Bank of New York Mellon Corpreduced · filed 6 Aug 2026 | 2,892,536$74.4M | -50,957−1.7% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.